Indication

Rickettsialpox

Rickettsialpox is a mild, self-limited, vector-borne zoonotic infectious disease caused by *Rickettsia akari*, an obligate intracellular bacterium primarily transmitted to humans through the bite of the house mouse mite (*Liponyssoides sanguineus*). Read more about Rickettsialpox

222 drugs 110 manufacturers

Advertisement

Drugs that treat it

Common Rickettsialpox therapies.

Showing 136–144 of 222 drugs

Filter & compare in the drug finder →Opens the drug finder with Rickettsialpox preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Rickettsialpox.

Rickettsialpox is a mild, self-limited, vector-borne zoonotic infectious disease caused by *Rickettsia akari*, an obligate intracellular bacterium primarily transmitted to humans through the bite of the house mouse mite (*Liponyssoides sanguineus*).

The condition predominantly affects the integumentary and systemic vascular systems, frequently occurring in urban environments where domestic rodent hosts are prevalent.

Pathophysiologically, localized bacterial proliferation produces an initial erythematous papule that ulcerates into a pathognomonic black inoculation eschar with regional lymphadenopathy.

This is typically followed several days later by an acute systemic phase marked by fever, chills, headache, and a generalized, chickenpox-like papulovesicular rash that crusts and heals without scarring.

Personalize your experience

Follow Rickettsialpox and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it